Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further t

American Capital Management Inc. bought a new position in shares of IDEXX Laboratories, Inc. (NASDAQ

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the

IDXX's CAG diagnostics and cloud software growth support recurring revenues, while FX exposure and d

IDEXX raises its 2026 EPS outlook as recurring diagnostics growth, wider margins and international e

IDEXX pairs resilient diagnostics growth, margin gains and expanding innovation with a premium valua

IDEXX Laboratories, Inc. (IDXX) Analyst/Investor Day Transcript

IDEXX Laboratories NASDAQ: IDXX outlined an innovation-led growth strategy at its 2026 Investor Day,

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investi

Barclays analyst Glen Santangelo maintains IDEXX Laboratories (NASDAQ:IDXX) with a Overweight and

WESTBROOK, Maine--(BUSINESS WIRE)--IDEXX announces Catalyst™ proBNP Test, the first and only dual-sp

IDEXX Laboratories remains a buy, supported by a durable moat, strong recurring revenue, and a long-

Aurora Investment Managers LLC. bought a new stake in IDEXX Laboratories, Inc. (NASDAQ: IDXX) in the

Idexx (IDXX) could produce exceptional returns because of its solid growth attributes.

Empowered Funds LLC cut its position in IDEXX Laboratories, Inc. (NASDAQ: IDXX) by 65.7% during the

IDEXX Laboratories (NASDAQ: IDXX) reported second-quarter 2026 revenue growth of approximately 10% o

UBS analyst Andrea Alfonso maintains IDEXX Laboratories (NASDAQ:IDXX) with a Neutral and raises t

Citigroup analyst Daniel Grosslight maintains IDEXX Laboratories (NASDAQ:IDXX) with a Neutral and

Revenue: Increased approximately 10% as reported and 9% organically.CAG Diagnostics Recurring Revenu

IDEXX Laboratories beats Q2 estimates, expands margins and raises its 2026 EPS outlook as diagnostic

IDEXX Laboratories, Inc. (IDXX) Q2 2026 Earnings Call Transcript

IDEXX Laboratories NASDAQ: IDXX reported second-quarter 2026 revenue growth of approximately 10% on

IDEXX Laboratories, Inc. (NASDAQ:IDXX) stock rose Tuesday after the veterinary diagnostics company r

IDEXX Laboratories (IDXX) stock rose after reporting Q2 earnings of $4.27/share and $1.22B in revenu

The headline numbers for Idexx (IDXX) give insight into how the company performed in the quarter end

IDEXX Laboratories (NASDAQ:IDXX) reported second-quarter financial results on Tuesday. The transcrip

IDEXX Laboratories (NASDAQ:IDXX) raises FY2026 GAAP EPS guidance from $14.45-$14.90 to $14.69-$14.94

IDEXX Laboratories (NASDAQ:IDXX) reported quarterly earnings of $4.27 per share which beat the analy

UBS analyst Andrea Alfonso maintains IDEXX Laboratories (NASDAQ:IDXX) with a Neutral and lowers t

Idexx Laboratories shares edge higher as revenue tops estimates but earnings per share misses; guida

IDEXX Laboratories (NASDAQ:IDXX) reported quarterly earnings of $3.47 per share which beat the analy

IDEXX Laboratories (NASDAQ:IDXX) raises FY2026 GAAP EPS guidance from $14.29-$14.80 to $14.45-$14.90

UBS analyst Andrea Alfonso maintains IDEXX Laboratories (NASDAQ:IDXX) with a Neutral and lowers t

Citigroup analyst Daniel Grosslight initiates coverage on IDEXX Laboratories (NASDAQ:IDXX) with a

Stifel analyst Jonathan Block maintains IDEXX Laboratories (NASDAQ:IDXX) with a Buy and lowers th

Piper Sandler analyst David Westenberg maintains IDEXX Laboratories (NASDAQ:IDXX) with a Neutral

Barclays analyst Glen Santangelo maintains IDEXX Laboratories (NASDAQ:IDXX) with a Overweight and

UBS analyst Andrea Alfonso maintains IDEXX Laboratories (NASDAQ:IDXX) with a Neutral and lowers t

BTIG analyst Mark Massaro maintains IDEXX Laboratories (NASDAQ:IDXX) with a Buy and lowers the pr

Dow Jones gains 500 points. Markets digest Trump's Fed chair nomination. CNN Money Fear & Gr

Wall Street rebounded at the start of the new month after Friday's broad sell-off, but pressure

IDEXX beat earnings and revenue estimates, boosted by strong pet diagnostics growth, and forecast so